When Takeda CEO Christophe Weber retires from the company in June 2026, a familiar face among the Massachusetts biotech scene will take over leading the Japanese pharma giant.
A fast-casual restaurant that serves Korean and Mexican food has received approval to open on Route 9 in Framingham.
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
6hon MSN
The Trump administration is poised to supercharge America’s appetite for supplements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback